APA (7th ed.) Citation

Yan Li, Yan Li, Qingying Huang, Yaoyao Zhou, Meizhi He, Jianhong Chen, . . . Xue Wang. (2019). The Clinicopathologic and Prognostic Significance of Programmed Cell Death Ligand 1 (PD-L1) Expression in Patients With Prostate Cancer: A Systematic Review and Meta-Analysis. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Yan Li, Yan Li, Qingying Huang, Yaoyao Zhou, Meizhi He, Jianhong Chen, Yubo Gao, and Xue Wang. The Clinicopathologic and Prognostic Significance of Programmed Cell Death Ligand 1 (PD-L1) Expression in Patients With Prostate Cancer: A Systematic Review and Meta-Analysis. Frontiers Media S.A., 2019.

MLA (9th ed.) Citation

Yan Li, et al. The Clinicopathologic and Prognostic Significance of Programmed Cell Death Ligand 1 (PD-L1) Expression in Patients With Prostate Cancer: A Systematic Review and Meta-Analysis. Frontiers Media S.A., 2019.